Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
SamaCare
United States
- San Francisco, California
- 22/05/2024
- Series B
- $17,000,000
We've built software to streamline the prior authorization process for for life-changing specialty medications. Our software offers medical practices a cloud-based solution to submit, track, and manage prior authorizations across their many payers and drugs. By digitizing the current manual paper-and-fax-heavy process, our platform reduces the administrative burdens that make patient care worse and drive up costs.
- Industry Technology, Information and Internet
- Website https://www.samacare.com/
- LinkedIn https://www.linkedin.com/company/sama-health/
Related People
Syam PalakurthyCo Founder
United States -
San Francisco Bay Area
SamaCare builds software to improve access to life-changing specialty medications. We work with healthcare providers, pharmaceutical manufacturers, and payers to streamline the process of prior authorization and other administrative obstacles in order to promote timely patient access to treatment for the most complex specialty medications.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)